Aleve and Dermatitis exfoliative - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative is reported as a side effect among people who take Aleve (naproxen sodium), especially for people who are female, 60+ old, also take Ibuprofen, and have Back pain.

The phase IV clinical study analyzes which people have Dermatitis exfoliative when taking Aleve. It is created by eHealthMe based on reports of 68,206 people who have side effects when taking Aleve from the FDA, and is updated regularly.

What is Aleve?

Aleve has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 70,279 Aleve users. Check the latest studies of Aleve.

What is Dermatitis exfoliative?

Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 682 drugs and 945 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative.

On Aug, 12, 2026

68,206 people reported to have side effects when taking Aleve.
Among them, 16 people (0.02%) have Dermatitis exfoliative.

Could Aleve cause Dermatitis exfoliative?

Among these 16 people:

What is the gender of people who have Dermatitis exfoliative when taking Aleve? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Dermatitis exfoliative when taking Aleve? *

What are other drugs people take besides Aleve? *

Acetaminophen: 2 people, 12.50%
Celebrex: 2 people, 12.50%
Pepcid: 2 people, 12.50%
Flexeril: 2 people, 12.50%
Chlorpheniramine Maleate: 2 people, 12.50%
Ibuprofen: 2 people, 12.50%
Byetta: 1 person, 6.25%
Demerol: 1 person, 6.25%
Kadian: 1 person, 6.25%
Bextra: 1 person, 6.25%

What are other side effects people have besides Dermatitis exfoliative? *

White Blood Cell Count Increased: 3 people, 18.75%
Feeling Hot: 2 people, 12.50%
Oedema Upper Limb (swelling of arm): 2 people, 12.50%
Dry Skin: 2 people, 12.50%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 2 people, 12.50%
Erythrocyte Sedimentation Rate Increased: 2 people, 12.50%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 12.50%
Nausea (feeling of having an urge to vomit): 2 people, 12.50%
Itching: 2 people, 12.50%
Palmar Erythema (reddening of the palms at the thenar and hypothenar eminences): 2 people, 12.50%

What are the existing conditions these people have? *

Back Pain: 2 people, 12.50%
Type 1 Diabetes: 1 person, 6.25%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.25%
Muscle Spasms (muscle contraction): 1 person, 6.25%
High Blood Cholesterol: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Aleve and have Dermatitis exfoliative?

- Check whether Dermatitis exfoliative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aleve:

Aleve (70,279 reports)

Browse all side effects of Aleve:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (682 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (945 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen sodium (the active ingredients of Aleve) and Aleve (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.